The treatment traps and neutralizes misfolded proteins to stop the progression of Alzheimer's disease and other neurodegenerative disorders.

Cell and gene therapies offer potential new therapeutics but are currently constrained by complex and inefficient manufacturing strategies.

Montreal-based Nomic Bio broadens its proteomics technology to offer a 1,000-plex protein measurement service.

Results highlight importance of addressing overwork as an occupational health concern, and the need for workplace policies to ...

Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy manufacturing.

A new spinoff company is about to launch a computer model that aims to accelerate process development by speeding up the optimization of cell culture media. AuctuGel, which plans to open for business ...

In this Revvity GENCast episode 2, experts will discuss applications of gene editing to improve scientists’ understanding of the relationship between variant and disease in functional genomics studies ...

Whether you’re working in a startup, academic lab, or biopharma R&D team, this eBook offers a window into what’s working now and what’s possible next.

Study in mice found transient microglial depletion, or chemokine receptor blockade, resolved immunotherapy-related cognitive impairment.

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

HHS Secretary Robert F. Kennedy Jr. and biopharmas will negotiate drug prices individually. Kennedy could "propose a ...